Trials / Unknown
UnknownNCT00202956
Safety and Efficacy Study of Bugusan (BGS)to Treat Osteoporosis.
A Randomized, Double Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Effects on Biomarkers and Safety of Bugusan (BGS) in Postmenopausal Patients With Osteoporosis.
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Taichung Veterans General Hospital · Academic / Other
- Sex
- Female
- Age
- 45 Years – 75 Years
- Healthy volunteers
- —
Summary
The objective is to evaluate the effects on biomarkers and safety of BGS in postmenopausal patients with osteoporosis.
Detailed description
The objective is to evaluate the effects on biomarkers and safety of BGS in postmenopausal patients with osteoporosis by a study of Randomized, Double Blind, Placebo-Controlled, Parallel Group.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Bugusan |
Timeline
- Start date
- 2004-06-01
- Completion
- 2005-05-01
- First posted
- 2005-09-20
- Last updated
- 2005-09-20
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT00202956. Inclusion in this directory is not an endorsement.